News Pfizer fears rough ride with NICE over breast cancer drug Concerns over NICE's treatment of add-on therapies.
News Juno halts CAR-T trial again after 2 more deaths Doubts over Juno CAR-T therapy after two more trial deaths.
News Janssen drug approved in combination against myeloma FDA backs Darzalex in multiple myeloma second line.
News Teva's Trisenox approved in first line for APL First ever chemotherapy-free regimen for rare leukaemia.
News Pfizer looks to confirm US licence for breast cancer pill Pfizer has filed late stage data with FDA.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
